chemo-immunotherapy

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  

chemo-immunotherapy
Sep 28, 2024, 07:13 | Blog
Stephen V Liu: Very different healthcare systems - very similar challenges and unanswered questions
Stephen V Liu shared a post on X: "Thanks to colleagues in China for a great…
Aug 5, 2024, 10:25 | Insight
5 papers about Lung Cancer suggested by Stephen Liu
Stephen Liu, Head of Developmental Therapeutics at Georgetown Lombardi Comprehensive Cancer Center, shared a few…
Aug 3, 2024, 08:51 | Blog
Filippo Gallina: PD-L1 testing in the context of neoadjuvant chemo-immunotherapy
Filippo Gallina, Research Fellow at McGill University Health, shared his recent article on X: "Happy…
Jul 24, 2024, 13:28 | Blog
Ruzanna Papyan: The significant role of anti-GD2 therapy in the treatment of relapsed or refractory neuroblastoma
Ruzanna Papyan shared a post on LinkedIn about a recent paper by Patricia Raiser et al., commenting:…
May 8, 2024, 07:02 | Insight
Piotr Wysocki: Immunotherapy after chemotherapy may be the right choice
Piotr Wysocki recently shared on LinkedIn: "Mariniello A. et al. published results of an important preclinical…
Apr 3, 2024, 06:05 | Blog
Most viewed in the last 7 days from JAMA Oncology
JAMA Oncology shared a post on LinkedIn: “Most viewed in the last 7 days from…
Mar 13, 2024, 16:26 | Blog
Shushan Hovsepyan: Does the choice of chemotherapy regimen make a difference in relapse/progressive high-risk neuroblastoma?
Shushan Hovsepyan, Pediatric Oncologist and Clinical Research Coordinator at the Yeolyan Hematology and Oncology Center,…
All: 7 Posts: 1 - 100
Special Coverage